Dr. Dan Theodorescu, director of Cedars-Sinai Cancer, is stepping down after six years to pursue new professional opportunities, Cedars-Sinai said this week. During Theodorescu’s tenure, Cedars-Sinai Cancer doubled its National Institutes of Health funding and expanded the scope and breadth of its research. 

Artificial intelligence provides more insights and a full picture of a patient, says Shane Cooke, president and CEO of Etiometry.  

Members of the Senate Finance Committee have reintroduced the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act, a bipartisan bill that would establish a Medicare Coverage pathway to new cancer detection technologies, including tests that can detect multiple types of cancer before symptoms appear.